• About us
    • Origin, aspirations and mission statement
    • Organization
  • The stakeholders
    • The operational team
    • Members
    • Committees
  • Submit a project
    • Types of projects
    • Support from the Association
    • The opportunities
  • Our achievements
    • Current projects
    • Dialogue with the French National Authority for Health
    • The Cancer Data Platform
  • IN THE HEADLINES
    • Interviews
    • News
  • Survey
  • Contact
Menu
  • About us
    • Origin, aspirations and mission statement
    • Organization
  • The stakeholders
    • The operational team
    • Members
    • Committees
  • Submit a project
    • Types of projects
    • Support from the Association
    • The opportunities
  • Our achievements
    • Current projects
    • Dialogue with the French National Authority for Health
    • The Cancer Data Platform
  • IN THE HEADLINES
    • Interviews
    • News
  • Survey
  • Contact
  • FR

Day: May 11, 2023

The Artificial Intelligence & Cancers Association and the commitment of its administrators: Interview with Patrick Meshaka, Medical Director – Novartis

For our second interview, Patrick Meshaka, Medical Director at Novartis, will answer our questions. You will discover why this laboratory has been present in health for more than 100 years has decided to join this project.  

Filière Intelligence Artificielle & Cancers

AMGEN | ARIIS | AstraZeneca | Bristol Myers Squibb | France Biotech | Health Data Hub | Institut national du cancer | JANSSEN | MSD | Novartis | Pfizer | Pierre Fabre | Roche Diagnostics

PariSanté Campus

2-10 rue d’Oradour-sur-Glane
75015 PARIS
  • Legal Mentions
  • Data protection and privacy
  • Contact
  • Legal Mentions
  • Data protection and privacy
  • Contact

Copyright © 2023 by mlcom. Tous les droits sont réservés.

Youtube Linkedin